Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Subscribe
Biotech
Cell & Gene Therapy
Clinical Data
Venture Capital
Deals
Research
Medtech
Devices
Diagnostics
AI and Machine Learning
CRO
Special Reports
Trending Topics
Diabetes
Fierce 50
Special Report
Awards Gala
Resources
Fierce Events
Industry Events
Webinars
Podcasts
Whitepapers
Survey
Events
Subscribe
Fierce Pharma
Fierce Biotech
Fierce Healthcare
Fierce Life Sciences Events
Advertise
About Us
Special report
: Fierce 15 nominations are now open! We're looking for the best and brightest in biotech.
Johnson & Johnson
Research
Rare blood clots caused by COVID shots, common cold share genes
The same gene appears to cause the rare blood clots linked to COVID vaccines from J&J and AstraZeneca and a reaction to adenovirus infection.
Helen Floersh
May 17, 2024 1:08am
J&J hooks Proteologix for at least $850M in cash
May 16, 2024 10:12am
J&J pulls pediatric electrosurgery pad after patient burn recall
May 10, 2024 2:10pm
J&J brings AI update to its heart-mapping Carto 3 system
May 8, 2024 10:15am
CG sets new bar in bladder cancer, months after huge IPO
May 3, 2024 11:23am
Addex's Janssen-partnered epilepsy drug fails phase 2 trial
Apr 29, 2024 8:44am